Table 2.
Bioanalyte concentrations in the first 48 h
| Bioanalyte (pg/mL)a | Non-transfused (n=33) |
Transfused (n=22) |
p-valueb |
|---|---|---|---|
| CCL2 | 532 (289) | 549 (262) | 0.834 |
| CCL3 | 132 (71) | 134 (77) | 0.904 |
| CCL4 | 468 (675) | 224 (159) | 0.130 |
| CCL5 | 21851 (21762) | 52165 (139348) | 0.270 |
| CCL11 | 65 (39) | 56 (23) | 0.376 |
| CXCL8 | 31 (21) | 84 (88) | 0.003 |
| CXCL9 | 135 (113) | 135 (111) | 0.996 |
| CXCL10 | 75 (70) | 62 (40) | 0.468 |
| GM-CSF | 86 (191) | 87 (146) | 0.991 |
| IL-1β | 65 (84) | 62 (87) | 0.893 |
| IL1-RA | 1360 (2656) | 2219 (2063) | 0.237 |
| IL-2 | 22 (24) | 25 (27) | 0.668 |
| IL-2R | 813 (393) | 1042 (700) | 0.148 |
| IL-4 | 139 (164) | 139 (58) | 0.995 |
| IL-5 | 68 (143) | 83 (129) | 0.703 |
| IL-6 | 201 (190) | 231 (186) | 0.596 |
| IL-7 | 187 (221) | 377 (465) | 0.060 |
| IL-10 | 24 (30) | 32 (36) | 0.402 |
| IL12p40 | 506 (273) | 467 (250) | 0.619 |
| IL13 | 51 (26) | 47 (26) | 0.591 |
| IL-15 | 72 (107) | 84 (100) | 0.705 |
| IL-17 | 132 (126) | 134 (92) | 0.904 |
| IFN-α | 93 (82) | 102 (78) | 0.692 |
| IFN-γ | 101 (59) | 125 (96) | 0.277 |
| TNF-α | 23 (24) | 14 (9) | 0.132 |
a
Plasma bioanalyte concentrations are reported as mean pg/mL (sd).
b
Comparisons were made between the non-transfused and transfused groups using two-sample t test with equal variances.